Lee Zeldin in ‘complete remission’ following leukemia treatment

319
SHARES
2.5k
VIEWS

You Might Also Like


– Advertisement –


Zeldin’s leukemia diagnosis was revealed early last November

– Advertisement –

Representative Lee. Zeldin, R.N.Y. announced Saturday that he is in “complete remission” after receiving treatment from a diagnosis of chronic myeloid leukemia (CML) last November.

“Through early detection, last November, I was diagnosed with early-stage chronic myeloid leukemia. I immediately began treatment with a positive response and no side effects,” Zeldin said in a statement. “Over the past 9 months, I have achieved complete remission, expect to live a normal life, and my doctor says there is no evidence of disease in my system. My health is phenomenal and I am 110% But I keep working.”

advertisement

Biden’s aides set up a ‘wall’ to protect against unreported incidents, book claims

“At no point have I slowed down at all and my lowest gear is always All In,” Zeldin said. “I have and will continue to perform all my duties in Congress and represent my constituents in NY-1 at the highest level. I have also not relinquished any Army Reserve duty as a result of this diagnosis.”

– Advertisement –

According to Zeldin’s hematologist Jeffrey Vaserka, MD, FACP of New York cancer and blood specialists, the congressman “started targeted therapy, to which he immediately responded exceptionally well and achieved complete remission.” Vacirca also noted that Zeldin is “incredibly healthy” and “expected to enjoy a normal life and have no evidence of illness.”

In his statement on the matter, Zeldin also commended the people in the medical field who assisted in his treatment.

“I am grateful to all the men and women in the medical field who have not only treated me over the past several months, but who put their heart and soul into treating the many others in need of their expertise, energy and passion. It is,” Zeldin said. “The medical field in our country is full of the very best societies.”


– Advertisement –

Related News

Next Post

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending News